Journal of Medicinal Chemistry · 2000 · 116 citations · 16 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignOrganic ChemistryStructure-activity RelationshipsAnti-inflammatory PharmacologyHeterocyclic ChemistryLead Compound DesignMedicinal PlantsStructure-activity Relationship AnalysisAnti-inflammatory ActivityAnticancer ActivityBioactive HeterocyclesMedicinal Chemistry ApplicationsMedicinal HeterocyclesNitric OxideNitric Oxide ProductionNitric Oxide Scavenging
We initially randomly synthesized about 60 oleanane and ursane triterpenoids as potential anti-inflammatory and cancer chemopreventive agents. Preliminary screening of these derivatives for inhibition of production of nitric oxide induced by interferon-gamma in mouse macrophages revealed that 3-oxooleana-1, 12-dien-28-oic acid (B-15) showed significant activity (IC(50) = 5.6 microM). On the basis of the structure of B-15, 19 novel olean- and urs-12-ene triterpenoids with a 1-en-3-one functionality having a substituent at C-2 in ring A have been designed and synthesized. Among them, 3-oxooleana-1,12-diene derivatives with carboxyl, methoxycarbonyl, and nitrile groups at C-2 showed higher activity than the lead compound B-15. In particular, 2-carboxy-3-oxooleana-1, 12-dien-28-oic acid (3) had the highest activity (IC(50) = 0.07 microM) in this group of triterpenoids. The potency of 3 was similar to that of hydrocortisone (IC(50) = 0.01 microM), although 3 does not act through the glucocorticoid receptor. Interesting structure-activity relationships of these novel synthetic triterpenoids are also discussed.
16
Aihao Ding, Carl Nathan, Jeannette L. Graycar et al. · The Journal of Immunology · 1990 · 500 citations
Anti-inflammatory activity of oleanolic acid in rats and mice
G. B. Singh, Surjeet Singh, Soheila Bani et al. · Journal of Pharmacy and Pharmacology · 1992 · 201 citations
Medicine, Pharmacology, Inflammation +14